Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175. Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Oct 2017 Should Physicians Consider the Environmental Effects of Prescribing Antibiotics? Jeremy Balch, Julia H. Schoen, MS, and Payal K. Patel, MD, MPH When prescribing antibiotics, physicians should weigh individual benefit against both environmental and community harms. AMA J Ethics. 2017;19(10):957-965. doi: 10.1001/journalofethics.2017.19.10.peer1-1710. History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.
Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.
Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Oct 2017 Should Physicians Consider the Environmental Effects of Prescribing Antibiotics? Jeremy Balch, Julia H. Schoen, MS, and Payal K. Patel, MD, MPH When prescribing antibiotics, physicians should weigh individual benefit against both environmental and community harms. AMA J Ethics. 2017;19(10):957-965. doi: 10.1001/journalofethics.2017.19.10.peer1-1710.
History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.